Ad
related to: duke oncology scheduling
Search results
Results From The WOW.Com Content Network
The Duke Cancer Institute (DCI) is a National Cancer Institute-designated Comprehensive Cancer Center, research facility, and hospital. [1] Founded in 1971, the center is part of the Duke University School of Medicine and Duke University Health System located in Durham, North Carolina, United States. [2] [3]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In 1990, Duke geneticists invented a three-minute test to screen newborns for over 30 metabolic diseases at one time. This practice has since become standard worldwide. In 1992, Duke's cancer center became the first hospital to develop an outpatient bone marrow transplant program. That same year, the hospital performed its first lung and heart ...
Potti was employed as a practicing physician at the Coastal Cancer Center [43] in Loris from March 2011 until 21 February 2012, when he was let go. [42] [44] [45] [46] In addition to the settlements, two lawsuits also have been filed against Potti, as well as against Duke and other medical personnel there, charging medical negligence among ...
The Levine Science Research Center (LSRC) is a 341,000-square-foot (31,700 m 2) facility on Duke University's west campus located at 308 Research Drive Durham, NC 27708. The LSRC is currently the largest single-site interdisciplinary research facility in the U.S.
From 1987 to 1989, Winer held a fellowship in hematology-oncology at Duke University Medical Center. From 1989 to 1997 he was on the faculty at Duke University Medical Center and served as co-director of the Duke University Medical Center Multidisciplinary Breast Program. He moved to Dana–Farber Cancer Institute after 10 years at Duke.
In 1954, before the trial was complete, Holland moved to Roswell Park Comprehensive Cancer Center (then known as Roswell Park Memorial Institute), but the new chief of oncology Gordon Zubrod at the NCI agreed to continue the trial, and a multicenter trial was thus born. In 1955, Congress granted $5 million for the study of chemotherapy and ...
His interests are in studying sarcomagenesis, cancer biology and radiation oncology. [2] His highest cited papers are "Conversion of Bcl-2 to a Bax-like death effector by caspases", [4] at 1332 times, and "Restoration of p53 function leads to tumour regression in vivo", [5] at 1320 times, according to Google Scholar.
Ad
related to: duke oncology scheduling